C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting

Blood Coagulation and Fibrinolysis

Volumn 24, Issue 3, 2013, Pages 321-326

  Kreutz, Rolf P ^a,b   Owens, Janelle ^b   Breall, Jeffrey A ^a   Lu, Deshun ^b   Lohe, Elisabeth Von Der ^a   Bolad, Islam ^a   Sinha, Anjan ^a   Flockhart, David A ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C reactive protein; clot strength; coronary artery disease; fibrin; thrombelastography

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; KAOLIN;

ADULT; ARTICLE; BLOOD CLOTTING; CORONARY ARTERY DISEASE; CORONARY STENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN CLOT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD COAGULATION; C-REACTIVE PROTEIN; CALCIUM CHLORIDE; CORONARY ARTERY DISEASE; FEMALE; FIBRIN; FIBRINOGEN; HUMANS; INFLAMMATION; KAOLIN; MALE; MIDDLE AGED; RISK FACTORS; STENTS; THROMBELASTOGRAPHY; THROMBOPHILIA; THROMBOSIS;

EID: 84875834946     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32835cc193     Document Type: Article

References (30)

1. Holmes DR Jr, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, et al. Stent thrombosis. J Am Coll Cardiol 2010; 56:1357-1365.
2. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study. J Am Coll Cardiol 2005; 46:1820-1826. (Pubitemid 41579802)
3. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91:1676-1688.
4. Stephens NG, Ludman PF, Petch MC, Schofield PM, Shapiro LM. Changing from intensive anticoagulation to treatment with aspirin alone for coronary stents: the experience of one centre in the United Kingdom. Heart 1996; 76:238-242. (Pubitemid 26290522)
5. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, et al., ATLAS ACS 2-TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012; 366:9-19.
6. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106:1366-1375. (Pubitemid 351571062)
7. Gurbel PA, Bliden KP, Navickas IA, Mahla E, Dichiara J, Suarez TA, et al. Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events. Am Heart J 2010; 160:346-354.
8. Breet NJ, van Werkum JW, Bouman HJ, Kelder JC, Ruven HJ, Bal ET, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. JAMA 2010; 303:754- 762.
9. Jeong YH, Bliden KP, Antonino MJ, Tantry US, Gurbel PA. Usefulness of thrombelastography platelet mapping assay to measure the antiplatelet effect of P2Y(12) receptor inhibitors and high on-treatment platelet reactivity. Platelets 2012 [Epub ahead of print].
10. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54:2129-2138.
11. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J, Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375:132-140.
12. Buffon A, Liuzzo G, Biasucci LM, Pasqualetti P, Ramazzotti V, Rebuzzi AG, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 1999; 34:1512-1521. (Pubitemid 29528666)
13. Schoos MM, Kelbæk H, Kofoed KF, Køber L, Kløvgaard L, Helqvist S, et al. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention. Am J Cardiol 2011; 107:1597-1603.
14. Park DW, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation 2009; 120:1987-1995.
15. Park DW, Lee SW, Yun SC, Song HG, Ahn JM, Lee JY, et al. A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. J Am Coll Cardiol 2011; 58:2630-2639.
16. Kreutz RP, Tantry US, Bliden KP, Gurbel PA. Inflammatory changes during the 'common cold' are associated with platelet activation and increased reactivity of platelets to agonists. Blood Coagul Fibrinolysis 2007; 18:713-718. (Pubitemid 350059328)
17. Kreutz RP, Alloosh M, Mansour K, Neeb Z, Kreutz Y, Flockhart DA, Sturek M. Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity. Diabetes Metab Syndr Obes 2011; 4:99-105.
18. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221 066 patients, and 4276 thromboses. Int J Cardiol 2012 [Epub ahead of print].
19. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA. Variability in individual responsiveness to clopidogrel: clinical implication, management, and future perspectives. J Am Coll Cardiol 2007; 49:1505-1516. (Pubitemid 46517957)
20. Gurbel PA, Bliden KP, Cohen E, Navickas IA, Singla A, Antonino MJ, et al. Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting. Blood Coagul Fibrinolysis 2008; 19:268-275. (Pubitemid 351670410)
21. Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, Gurbel PA. Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the Thrombotic RIsk Progression (TRIP) study. Platelets 2010; 21:360-367.
22. Gurbel PA, Bliden KP, Kreutz RP, Dichiara J, Antonino MJ, Tantry US. The link between heightened thrombogenicity and inflammation: preprocedure characterization of the patient at high risk for recurrent events after stenting. Platelets 2009; 20:97-104.
23. Rafiq S, Johansson PI, Ostrowski SR, Stissing T, Steinbru? chel DA. Hypercoagulability in patients undergoing coronary artery bypass grafting: prevalence, patient characteristics and postoperative outcome. Eur J Cardiothorac Surg 2012; 41:550-555.
24. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005; 100:1576-1583. (Pubitemid 40712703)
25. Brooks GC, Blaha MJ, Blumenthal RS. Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 2010; 106:56-61.
26. Nielsen VG, Gurley WQ Jr, Burch TM. The impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 2004; 99:120-123. (Pubitemid 38808177)
27. Nielsen VG, Cohen JB, Malayaman SN, Nowak M, Vosseller K. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report. Blood Coagul Fibrinolysis 2011; 22:443-447.
28. Nielsen VG, Arkebauer MR, Vosseller K. Redox-based thrombelastographic method to detect carboxyhemefibrinogenmediated hypercoagulability. Blood Coagul Fibrinolysis 2011; 22:657-661.
29. Machovec KA, Ushakumari DS, Welsby IJ, Nielsen VG. The procoagulant properties of purified fibrinogen concentrate are enhanced by carbon monoxide releasing molecule-2. Thromb Res 2012; 129: 793-796.
30. Undas A, Zalewski J, Krochin M, Siudak Z, Sadowski M, Pregowski J, et al. Altered plasma fibrin clot properties are associated with in-stent thrombosis. Arterioscler Thromb Vasc Biol 2010; 30:276-282.